BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Deals

  Aquestive Therapeutics Announces Pricing of Initial Public Offering

  Aquestive Therapeutics, Inc. announced the pricing of its initial public offering of 4,500,000 shares of common stock at a public offering price of $15.00 per share for aggregate gross proceeds of $67,500,000.

  July 24, 2018

   · 

  2 min read
• Policy

  Biocom Applauds House Passage of Legislation to Repeal the Medical Device Tax

  Biocom issued the following statement regarding the passage of H.R. 184, the Protect Medical Innovation Act, in the U.S. House of Representatives by a 283-132 vote.

  July 24, 2018

   · 

  2 min read
• Policy

  CoQ-10 Class Action Settlement

  A proposed settlement has been reached in a class action lawsuit involving Lang Pharma Nutrition, Inc., a manufacturer of CoQ-10 supplements, and Wal-Mart Stores, Inc., CVS Pharmacy, Inc., Walgreen Company, and Meijer Distribution, Inc, retailers.

  July 24, 2018

   · 

  3 min read